2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aluminum Oxide

證據等級: L5 預測適應症: 0

目錄

  1. 2 3 7 8-Tetrachlorodibenzo-P-Dioxin Aluminum Oxide
  2. Multi-Substance Entry (20 Components): Insufficient Data for Drug Repurposing Evaluation
    1. One-Sentence Summary
    2. Quick Overview
    3. Why This Prediction Cannot Be Evaluated
    4. Conclusion and Next Steps
    5. Disclaimer

## 藥師評估報告

Multi-Substance Entry (20 Components): Insufficient Data for Drug Repurposing Evaluation

One-Sentence Summary

This Evidence Pack contains 20 unrelated chemical substances consolidated into a single query entry (including 2,3,7,8-TCDD, benzene, glyphosate, formaldehyde, and others), rather than a single drug candidate. The TxGNN model returned no predicted indications, and there are no clinical trials or publications associated with this combined entry. This record cannot proceed to standard repurposing evaluation in its current form.


Quick Overview

Item Content
Original Indication None on record
Predicted New Indication None — TxGNN returned no predictions
TxGNN Prediction Score N/A
Evidence Level L5 (model prediction only — and no prediction was generated)
US Market Status Not marketed
Number of NDAs 0
Recommended Decision Hold

Why This Prediction Cannot Be Evaluated

The inn field in this Evidence Pack is not a single drug. It is a semicolon-delimited list of 20 chemically unrelated substances:

# Substance Category
1 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Persistent organic pollutant / known carcinogen
2 Aluminum oxide Industrial abrasive / excipient
3 Antipyrine Analgesic / diagnostic agent
4 Benzene Industrial solvent / known carcinogen (IARC Group 1)
5 Bisphenol A Endocrine disruptor / plasticizer
6 Carbon disulfide Industrial chemical / neurotoxin
7 Carboxymethylcellulose sodium Pharmaceutical excipient
8 Diethylstilbestrol Synthetic estrogen (withdrawn from most markets)
9 Estrone Endogenous estrogen
10 Formaldehyde solution Fixative / known carcinogen (IARC Group 1)
11 Garlic Food substance / herbal supplement
12 Glyphosate Herbicide
13 Kerosene Petroleum distillate
14 Methylparaben Preservative / excipient
15 Naphthalene Industrial chemical / possible carcinogen
16 Paraffin Wax / excipient
17 Phenacetin Withdrawn analgesic (nephrotoxic)
18 Phenol Antiseptic / industrial chemical
19 Polytetrafluoroethylene (PTFE) Polymer / coating material
20 Ptelea trifoliata bark Herbal botanical

These substances share no common therapeutic indication, mechanism of action, or pharmacological class. They cannot be evaluated as a unified drug candidate. The TxGNN model’s failure to return any predictions is consistent with this data quality issue — the model could not identify a valid drug node in the knowledge graph for this concatenated query.


Conclusion and Next Steps

Decision: Hold

Rationale: This entry is the result of a data pipeline error in which 20 unrelated substances were concatenated into the inn field of a single candidate record. There is no drug identity, no original indication, no predicted indication, and no safety profile to evaluate.

To proceed, the following is needed:

  • Root cause investigation: Identify which upstream pipeline step produced this multi-substance concatenation (check candidate_id: TW-UNKNOWN-multi and the v4 generation process)
  • Re-submission as individual entries: Each substance that is a legitimate drug candidate (e.g., Antipyrine, Diethylstilbestrol, Estrone) should be submitted as a separate Evidence Pack with its own candidate_id
  • Exclusion of non-drug substances: TCDD, benzene, glyphosate, kerosene, formaldehyde, and naphthalene are environmental toxins or industrial chemicals — these should be filtered out at the data ingestion stage before reaching the repurposing pipeline
  • DrugBank ID validation gate: The pipeline should reject any entry with drugbank_id: null until a valid DrugBank ID is confirmed
  • MOA and regulatory data: For any legitimate candidates separated from this entry, DrugBank MOA and TFDA package insert data must be retrieved before safety evaluation can begin

    Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.



Copyright © 2026 UsTxGNN Project. For research purposes only.

This site uses Just the Docs, a documentation theme for Jekyll.